-
)
Over the past two decades, advanced therapies have transformed healthcare—from the first FDA-approved cell therapy to CR ... -
)
As gene therapies expand their clinical development and therapeutic reach Biotech’s are always looking for better ways o ... -
)
With the rise of allogeneic cell therapies, the cell and gene therapy industry stands at a potential turning point. In t ... -
)
In this in-depth interview with Genezen’s Founder and Executive Chairman, Bill Vincent, we unpack the evolving landscape ... -
)
Adeno-associated viral vectors have quickly become the vector of choice for many gene therapy developers. With a strong ...